Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
SightLife Surgical
Seattle, Washington, United States
- Ownership
- Private
- Employees
- ~225
- Development stage
- Other
01
Overview
SightLife Surgical was the largest provider of corneal transplant tissue in the world, specializing in the recovery, processing, and placement of donor corneas, and surgical devices for corneal surgeons. It developed innovative technologies and services to improve outcomes in corneal surgery, with a significant track record in global sight restoration efforts. The company was acquired and merged into CorneaGen and, ultimately, ownership/control transferred to Lions Eye Institute.
- Therapeutic areas
- Ophthalmology
- Modalities
- Device
- Industry
- Surgical Medical Devices
Beyond the preview
Go deeper on SightLife Surgical.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on SightLife Surgical.